BrainStorm Cell Therapeutics Inc (BCLI)

[early_retirement2]

Spideyboy - I just read your posts and I agree. I think some investors who aren't familiar with the process and the news gave them additional insight. Although, the cryopreservation process may not be a new process, I think the important points to take away from that PR is from the second paragraph (regardless of someone's knowledge of the company) :

"The validation involved a comparison of NurOwn® (MSC-NTF cells) derived from fresh mesenchymal stem cells (MSC) to those derived from cryopreserved MSC. Company scientists were successful in showing that the MSC can be stored in the vapor phase of liquid nitrogen for prolonged periods of time while maintaining their characteristics. The cryopreserved MSC are capable of differentiating into NurOwn®, similar to the NurOwn® derived from fresh MSC of the same patient/donor, prior to cryopreservation. This will allow the Company to provide repeated doses of autologous NurOwn® from a single bone marrow aspirate in its upcoming multidose clinical trial. Cryopreservation will avoid the need for patients to undergo repeated bone marrow aspirations. "


You bring up a good point about how viable the cells are after being thawed. Maybe you could follow up with the company and see if they would comment on that? Another good point is cash to support Phase III. To be honest, I was hoping we would have heard more about this by now. During the conference call in December, the CEO wasn't concerned about Phase III funding which lead me to believe they had a plan or serious investors willing to fund it...However, fast forward to present we know the CEO attended two large conference to discuss their progress. Anyone who listened on the conference call heard the CEO say he wouldn't go on the road to promote the company but he's done two conference already. But I will say, since he's presented at these conferences, the stock has slowly moved up... seems to be working for now. I think Phase III funding is one of their largest obstacles and yes, the stock may take a hit short-term but I believe long-term we'll be rewarded.

Here's a good read which compares BCLI with other companies, make sure you read the disclosure info at the bottom.

http://jutiagroup.com/20170116-time-to-go-long-on-brainstorm-cell-therapeutics/